Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Experts in Virus and Vaccine Research Meet to Re-Examine 2009 Swine Flu Outbreak and Strategize for a Future H1N1 Pandemic

The May 24 symposium, “H1N1 Swine Flu: The 2010 Perspective,” is presented by the Academy's Emerging Infectious Diseases & Microbiology Discussion Group in partnership with the Dr. Paul Janssen Memorial Series.

Published May 05, 2010


Recent reports have suggested that the 2009 global swine influenza (H1N1) pandemic was not as mild as many believe it to have been, and that H1N1 has become the dominant seasonal flu strain worldwide. Influenza viruses pose a major global public health threat. Understanding the pathogenicity and transmission of these viruses is of utmost importance in order to develop improved methods of prevention and control and to overcome shortcomings in the global public health response system that were exposed during the 2009 outbreak.


A May 24 afternoon symposium presented by the New York Academy of Sciences’ Emerging Infectious Diseases & Microbiology Discussion Group in partnership with the Dr. Paul Janssen Memorial Series will re-examine the 2009 swine influenza/H1N1 outbreak and provide a 2010 update, taking lessons from last year’s outbreak to prepare more effective public health responses for the next one.


This symposium, “H1N1 Swine Flu: The 2010 Perspective,” will revisit the 2009 outbreak and examine strategies against future outbreaks with presentations on virulence, transmission, the New York City experience, vaccine development, and the public health implications of a worldwide pandemic. A roundtable discussion featuring all speakers will reflect on the successes and problems during the 2009 outbreak, whether this can be considered a rehearsal for more virulent outbreaks, and updated strategies to confront new pandemics.


This program will also be broadcast as a live webinar, providing an opportunity for non-local delegates to participate in this exciting and timely discussion. A panel discussion will take place, moderated by Philip Dormitzer Head of the Viral Advanced Programs Global Project Team at Novartis Vaccines and Diagnostics. A networking reception will follow the event.

WHAT: H1N1 Swine Flu: The 2010 Perspective
WHO: Organizers: Doris Bucher, PhD, Associate Professor of Microbiology and Immunology, New York Medical College & Jennifer Henry, PhD, Director, Life Sciences, The New York Academy of Sciences
WHERE: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St., 40th floor
WHEN: Monday, May 24, 2010 | 1:00 PM - 5:30 PM

Speakers at this symposium are leading experts in virus and vaccine research:
Jose Galarza, CEO and founder of TechnoVax, Inc.
James Gill, Deputy Chief Medical Examiner of the Bronx Office of Chief Medical Examiner of the City of New York.
Anice Lowen , Department of Microbiology at Mount Sinai School of Medicine.
James Matthews, Vice President for Health and Science Policy at Sanofi Pasteur.
Michael Shaw, Associate Director for Laboratory Science in the Influenza Division of the National Center for Immunization and Respiratory Disease at the CDC in Atlanta.
Terrence Tumpey, Microbiologist and Team Leader of Pathogenesis, within the Immunology and Pathogenesis Branch at the CDC.

To register for “H1N1 Swine Flu: The 2010 Perspective,” or the webinar, please visit the <a href=””>New York Academy of Sciences website</a>. Media must register in advance by contacting Adrienne Burke, or Jennifer Henry,

“H1N1 Swine Flu: The 2010 Perspective” is supported by an educational grant from Gilead Sciences, Inc. and is part of the Academy’s Translational Medicine Initiative, sponsored by the Josiah Macy Jr. Foundation,

The New York Academy of Sciences is an independent, not-for-profit organization committed to advancing science, technology, and society worldwide since 1817. With 24,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large.

The Josiah Macy, Jr. Foundation is a privately endowed philanthropy located in the borough of Manhattan, New York City. The Foundation supports programs designed to improve the education of health professionals in the interest of the health of the public, and to enhance the representation of minorities in the health professions.